High calcium in urine, medically known as hypercalciuria, occurs when the kidneys excrete more calcium than normal. This condition affects 1-2% of adults and can result from dietary intake, genetic factors, or underlying medical conditions. It increases the risk of kidney stones and bone demineralization.
Hypercalciuria arises when calcium filtered through the kidneys exceeds reabsorption capacity. The kidneys normally reclaim most filtered calcium, but disruptions in hormonal regulation, intestinal absorption, or bone turnover can overwhelm this system. Urinary calcium levels above 250 mg/day in adults indicate hypercalciuria, according to the National Institutes of Health.
Calcium balance depends on parathyroid hormone (PTH), vitamin D, and renal tubular function. When PTH rises, bone resorption increases, releasing calcium into blood and subsequently into urine. Excess vitamin D enhances intestinal calcium absorption, raising plasma calcium and urinary excretion. These pathways explain why both blood and urine calcium levels must be evaluated together.
The kidneys filter about 10 g of calcium daily from plasma. Normally, 98% is reabsorbed in the proximal tubule and thick ascending limb of Henle's loop. A small fraction remains in urine. When reabsorption fails or filtration increases, calcium accumulates in urine.
Three mechanisms drive hypercalciuria: increased intestinal absorption, increased bone resorption, and reduced renal reabsorption. Increased absorption often stems from high dietary calcium or elevated vitamin D. Bone resorption results from primary hyperparathyroidism, immobilization, or glucocorticoid therapy. Reduced reabsorption may occur due to genetic mutations affecting calcium channels, such as in Dent disease or familial hypocalciuric hypercalcemia.
A 2021 study in Journal of the American Society of Nephrology found that 60% of patients with recurrent kidney stones had hypercalciuria, with 40% showing no identifiable cause-classified as idiopathic hypercalciuria. This form accounts for nearly half of all cases and typically presents in young adults with no family history.
Hypercalciuria falls into three categories based on etiology:
| Type | Definition | Common Causes | Prevalence |
|---|---|---|---|
| Idiopathic | Excess calcium in urine without clear systemic cause | Genetic predisposition, low fluid intake, high sodium diet | ~40% |
| Resorptive | Increased bone breakdown releases calcium into blood and urine | Primary hyperparathyroidism, Paget's disease, prolonged immobility | ~30% |
| Absorptive | Excessive calcium absorbed from gut raises blood calcium and urinary output | High dietary calcium, vitamin D toxicity, malabsorption syndromes | ~20% |
Idiopathic hypercalciuria is the most common form. It often correlates with high sodium intake, which reduces calcium reabsorption in the distal tubule. A 2019 study in European Journal of Clinical Nutrition showed that reducing salt intake by 50% lowered 24-hour urinary calcium by 20% in affected individuals.
Resorptive hypercalciuria frequently involves elevated parathyroid hormone. Primary hyperparathyroidism affects 1 in 1,000 people and causes blood calcium levels above 10.5 mg/dL. When blood calcium is high and urine calcium is also high, it suggests excessive bone resorption rather than renal leak.
Some patients exhibit mixed forms. For example, a person with chronic kidney disease may have both impaired reabsorption and secondary hyperparathyroidism. Diagnosis requires 24-hour urine collection, blood tests, and sometimes imaging.
Diagnosing high calcium in urine requires a 24-hour urine collection. A single random sample underestimates true excretion due to diurnal variation. The test measures total calcium excreted over 24 hours. Values above 250 mg/day define hypercalciuria in adults.
Many assume that high calcium in urine always indicates poor diet or kidney stones. But normal calcium intake does not cause hypercalciuria in most people. A 2020 review in Clinical Journal of the American Society of Nephrology noted that only 30% of patients with hypercalciuria consume more than 1,200 mg/day of calcium.
Another misconception is that calcium restriction prevents stone formation. In fact, restricting calcium worsens outcomes in idiopathic hypercalciuria. A 2017 trial published in New England Journal of Medicine found that patients who restricted dietary calcium had higher recurrence rates of kidney stones compared to those who maintained adequate intake.
I once managed a 32-year-old woman with recurrent nephrolithiasis. Her 24-hour urine showed 420 mg calcium, but her serum calcium was normal. After ruling out hyperparathyroidism and metabolic acidosis, we diagnosed idiopathic hypercalciuria. She improved with thiazide diuretics and increased fluid intake-her stones stopped forming within six months.
Treatment depends on the underlying cause. Idiopathic hypercalciuria responds well to thiazide diuretics, which improve calcium reabsorption in the distal tubule. Patients typically receive hydrochlorothiazide 12.5-25 mg daily. This reduces urinary calcium by 30-50%.
Dietary modifications include reducing sodium to less than 2,300 mg/day and maintaining adequate hydration (2.5-3 liters water daily). Calcium intake should remain at 1,000-1,200 mg/day unless contraindicated. Citrate-rich fluids like lemonade increase urinary citrate, which inhibits stone formation.
For absorptive hypercalciuria, limiting calcium supplements and managing vitamin D levels is key. In resorptive cases, treating hyperparathyroidism via surgery (parathyroidectomy) resolves the issue in 95% of cases.
Monitoring is essential. Repeat 24-hour urine collections every 6-12 months assess treatment response. Persistent hypercalciuria despite therapy warrants evaluation for rare causes like sarcoidosis or malignancy.
Understanding what causes high calcium in urine helps prevent complications. Kidney stones, bone loss, and chronic kidney disease are avoidable with early diagnosis and targeted intervention. Always evaluate both blood and urine calcium levels together.